Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel C Jankowitz

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2024
Impact of the Breast Cancer Index for Extended Endocrine Decision-Making: First Results of the Prospective BCI Registry StudyTara B Sanft, Jenna Wong, Brandon O'Neal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrenceYi Zhang, Catherine A Schnabel, Brock E Schroeder, et al.
Bone|March 29, 2016
Risedronate may preserve bone microarchitecture in breast cancer survivors on aromatase inhibitors: A randomized, controlled clinical trialChaithra Prasad, Susan L Greenspan, Karen T Vujevich, et al.
Cancer Medicine|January 14, 2017
Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancerTheresa A Koleck, Catherine M Bender, Susan M Sereika, et al.
Annals of Surgical Oncology|July 17, 2023
Temporal Trends and Factors Associated with Receipt of Post-mastectomy Radiation After Neoadjuvant Chemotherapy in Women with cT3 Breast CancerRitika Manik, Connor B Grady, Leisha C Elmore, et al.
American Journal of Clinical Pathology|February 27, 2018
Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast CancerBeth Z Clark, Daniel J Farrugia, Alessandra Landmann, et al.
Breast Cancer Research : BCR|June 27, 2020
Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histologyMartin Blohmer, Li Zhu, Jennifer M Atkinson, et al.
Journal of the National Cancer Institute|August 4, 2012
Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse modelShivendra V Singh, Su-Hyeong Kim, Anuradha Sehrawat, et al.
Annals of Surgical Oncology|July 16, 2021
Immediate Breast Reconstruction for Inflammatory Breast Cancer: Trends in Use and Clinical Outcomes 2004-2016Daniel I Hoffman, Patricia Mae G Santos, Macy Goldbach, et al.
Oncology Nursing Forum|April 29, 2014
Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancerCatherine M Bender, Amanda L Gentry, Adam M Brufsky, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2024
Impact of the Breast Cancer Index for Extended Endocrine Decision-Making: First Results of the Prospective BCI Registry StudyTara B Sanft, Jenna Wong, Brandon O'Neal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrenceYi Zhang, Catherine A Schnabel, Brock E Schroeder, et al.
Bone|March 29, 2016
Risedronate may preserve bone microarchitecture in breast cancer survivors on aromatase inhibitors: A randomized, controlled clinical trialChaithra Prasad, Susan L Greenspan, Karen T Vujevich, et al.
Cancer Medicine|January 14, 2017
Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancerTheresa A Koleck, Catherine M Bender, Susan M Sereika, et al.
Annals of Surgical Oncology|July 17, 2023
Temporal Trends and Factors Associated with Receipt of Post-mastectomy Radiation After Neoadjuvant Chemotherapy in Women with cT3 Breast CancerRitika Manik, Connor B Grady, Leisha C Elmore, et al.
American Journal of Clinical Pathology|February 27, 2018
Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast CancerBeth Z Clark, Daniel J Farrugia, Alessandra Landmann, et al.
Breast Cancer Research : BCR|June 27, 2020
Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histologyMartin Blohmer, Li Zhu, Jennifer M Atkinson, et al.
Journal of the National Cancer Institute|August 4, 2012
Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse modelShivendra V Singh, Su-Hyeong Kim, Anuradha Sehrawat, et al.
Annals of Surgical Oncology|July 16, 2021
Immediate Breast Reconstruction for Inflammatory Breast Cancer: Trends in Use and Clinical Outcomes 2004-2016Daniel I Hoffman, Patricia Mae G Santos, Macy Goldbach, et al.
Oncology Nursing Forum|April 29, 2014
Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancerCatherine M Bender, Amanda L Gentry, Adam M Brufsky, et al.
Pageof 6